Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

Journal of the National Cancer Institute - 3 Feb 1999

Lee J S, Wacholder S, Struewing J P, McAdams M, Pee D, Brody L C, Tucker M A, Hartge P

Abstract excerpt

BACKGROUND: Studies of survival following breast and ovarian cancers in BRCA1 and/or BRCA2 mutation carriers have yielded conflicting results. We undertook an analysis of a community-based study of Ashkenazi Jews to investigate the effect of three founder mutations in BRCA1 and BRCA2 on survival among patients with breast or ovarian cancer. METHODS: We collected blood samples and questionnaire data from 5318...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Linear Models

Share to Ovarian Neoplasms

Share to Survival Analysis

Share to Survival Rate

Source

Identifiers

PMID: 10037104
DOI: 10.1093/jnci/91.3.259

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.PMID 10037104Read ↗

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.Semantic proximity Read ↗

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentSemantic proximity Read ↗

Breast Conservation Therapy for Invasive Breast Cancer in Ashkenazi Women With BRCA Gene Founder MutationsSemantic proximity Read ↗

Effect of BRCA germline mutations on breast cancer prognosisSemantic proximity Read ↗

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Hereditary breast cancer in Jews.Semantic proximity Read ↗

BRCA-associated breast cancer in young women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.